Mandate

Investor Growth Capital investing in SciBase AB

August 15, 2006

Investor Growth Capital, SEB and CapMan are investing SEK 100 million in the medical technology company SciBase AB. The investment means that Investor Growth Capital, together with the former owners SEB Företagsinvest and CapMan will control 80% of the Swedish medical technology company.

Vinge acted as advisor to Investor Growth Capital and representatives from Vinge included Johan Winnerblad and Johan Larsson.

Related

Vinge has advised Axcel VI and Currentum in connection with the acquisition of Klarins Rör

Vinge has advised Axcel VI and the Currentum Group in connection with the acquisition of Klarins Rör i Göteborg AB (“Klarins Rör”).
December 09, 2025

Vinge advises on the sale of RK Projektledning to Qflow

Vinge has advised the sellers in connection with the sale of all shares in RK Projektledning AB to Qflow Group.
December 05, 2025

Vinge represents IKEA Forestry Investment AB in connection with the acquisition of forest land in Latvia and Lithuania

Vinge assists IKEA Forestry Investment AB (a company within the Inter IKEA group) in the acquisition of a Latvian and a Lithuanian company from Dasos Timberland Fund II (a fund managed by CapMan Natural Capital).
December 05, 2025